• 1
    Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000;342: 15001507.
  • 2
    The American College of Obstetricians and GynecologistsAssessment of risk factors for preterm birth. ACOG Practice Bulletin No. 31. Obstet Gynecol 2001;98: 709716.
  • 3
    Goldenberg RL, Klebanoff M, Carey JC, et al. Vaginal fibronectin measurements from 8 to 22 weeks', gestation and subsequent spontaneous preterm birth. Am J Obstet Gynecol 2000;183: 469475.
  • 4
    Leitich H, Egarter C, Kaider A, Hohlagschwandtner M, Berghammer P, Husslein P. Cervicovaginal fetal fibronectin as a marker for preterm delivery: a meta-analysis. Am J Obstet Gynecol 1999;180: 11691176.
  • 5
    Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med 1991;10: 16651677.
  • 6
    Goldenberg RL, Klebanoff M, Carey JC, MacPherson C, for the National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network Metronidazole treatment of women with a positive fetal fibronectin test result. Am J Obstet Gynecol 2001;185: 485486.